Status:
UNKNOWN
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Balanced Chromosomal Translocation
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
For every child with developmental delay, the investigators do a constitutional karyotype. This karyotype can reveal an apparently balanced chromosomal rearrangement (no visible loss or gain of geneti...
Detailed Description
Psychomotor delay is observed in approximately 3% of the general population and has various causes: environmental, genetic (gene or chromosome) or unknown. Chromosomal abnormalities have been identifi...
Eligibility Criteria
Inclusion
- patient with syndromic psychomotor delay
- patient with a apparently balanced de novo chromosomal translocation
- patient with health insurance
- informed consent signed by patient or by parents or by the legal representative for children
Exclusion
- patient with an inherited translocation
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01826708
Start Date
October 1 2011
End Date
April 1 2015
Last Update
December 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Chromosomal Genetics - Universitary Hospital
Montpellier, France, 34295